| Other current payables and liabilities |
18. Other current payables and liabilities Other payables as of December 31, 2023, and December 31, 2022, are as follows:
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
(Unit: USD) |
|
|
|
|
|
|
|
|
|
|
|
25,324,072 |
|
|
|
4,132,680 |
|
Accrued Expense |
|
|
1,518,801 |
|
|
|
1,558,085 |
|
|
|
|
|
|
|
|
|
|
Total |
|
|
26,842,873 |
|
|
|
5,690,765 |
|
|
|
|
|
|
|
|
|
|
| (*) |
As of December 31, 2023, the balance of non-trade payables primarily consists of USD 17,361,197 of legal and other professional fees incurred in preparation for and execution of the De-SPAC transaction, which are non-recurring. The Company has entered into deferred fee agreements (“DFA”) with numerous transaction advisors to spread payments over two years. The current balance represents 50% of the total deferred fee payables. | Other current liabilities as of December 31, 2023, and December 31, 2022, are as follows:
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
(Unit: USD) |
|
|
|
|
|
|
|
|
Withholdings |
|
|
21,184 |
|
|
|
15,086 |
|
Value added tax withheld |
|
|
207,310 |
|
|
|
208,186 |
|
Advance Received |
|
|
746,417 |
|
|
|
576,299 |
|
|
|
|
|
|
|
|
|
|
Total |
|
|
974,911 |
|
|
|
799,571 |
|
|
|
|
|
|
|
|
|
|
|